Platform Leadership

Faranak Farzan, PhD

Active Sites

The EEG Platform operates at the following research sites:

  • Centre for Addiction and Mental Health (Toronto, Ontario)
  • Queen’s University (Kingston, Ontario)
  • Rotman Research Institute, Baycrest (Toronto, Ontario) *analysis site only
  • Simon Fraser University (Surrey, British Columbia)
  • University of British Columbia (Vancouver, British Columbia)
  • University Health Network (Toronto, Ontario)

Platform Overview

The Electroencephalography (EEG) Platform is responsible for the collection, standardization and analysis of brain electrical activity data, also known as electrophysiological or EEG data. This platform studies patterns of electrical activity in the brain during rest, while performing functional tasks, and in response to non-invasive brain stimulation such as Transcranial Magnetic Stimulation (TMS). The platform has an overarching aim of identifying EEG biomarkers, and subsequently developing EEG-based healthcare technologies that could be used in both research centres and clinics to diagnose depression, predict response to various depression treatments, and guide design of novel targeted therapies. The development of such healthcare technologies requires standardized data collection and integration across multiple participating EEG sites. The EEG Platform provides leadership in this pursuit and interacts with other platforms to identify an optimal integrated technology for transforming lives of individuals with depression.